SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-005627
Filing Date
2020-04-01
Accepted
2020-04-01 17:02:17
Documents
53
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 380006
2 ex31-1.htm EX-31.1 12374
3 ex31-2.htm EX-31.2 12191
4 ex32-1.htm EX-32.1 8738
  Complete submission text file 0001493152-20-005627.txt   2645930

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE asnb-20191231.xml EX-101.INS 434619
6 XBRL SCHEMA FILE asnb-20191231.xsd EX-101.SCH 32266
7 XBRL CALCULATION FILE asnb-20191231_cal.xml EX-101.CAL 34299
8 XBRL DEFINITION FILE asnb-20191231_def.xml EX-101.DEF 129399
9 XBRL LABEL FILE asnb-20191231_lab.xml EX-101.LAB 246593
10 XBRL PRESENTATION FILE asnb-20191231_pre.xml EX-101.PRE 204252
Mailing Address 229 ANDOVER STREET WILMINGTON MA 01887
Business Address 229 ANDOVER STREET WILMINGTON MA 01887 978-657-0075
AdvanSource Biomaterials Corp (Filer) CIK: 0001011060 (see all company filings)

IRS No.: 043186647 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-11737 | Film No.: 20766107
SIC: 3841 Surgical & Medical Instruments & Apparatus